Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • CommuniquĂ© 53 Cover Image

Digital Therapeutics Landscape in Europe

September 3, 2020 |  

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

Digital Therapeutics Landscape in Europe: The Case of Germany and the UK

The COVID-19 virus crisis has opened immense windows of opportunity in healthcare around the globe. One of the greatest opportunities is in digital health, and in particular, digital therapeutics (DTx). The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide.1 As the interest in and use of digital health has grown during this period, we anticipate that investments in digital health tools will continue to accelerate after the COVID-19 pandemic. When the COVID-19 outbreak started, millions of Chinese people turned to online doctors and online health tools1 to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry 4.0 in healthcare for the benefit of patients.

HIGHLIGHTS INCLUDE:
  • Opportunities and threats of digital therapeutics after COVID-19
  • Digital therapeutics landscape in the European Union
  • Review and comparison of the German and UK therapeutics landscape
  • Develop game-changing insights and competitive advantage on both a global and local scalepi

Pink divider

Download the white paper and learn how it’s happening now!

Download the Paper- PMLiVE

  1. https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.html

This content was provided by OPEN Health

Company Details

OPEN Health

OPEN Health

Email
Website

 Latest Content from  OPEN Health 

Yurie Oates, Account Director, OPEN Health gives us some Top tips from 5 years of account management on #MedCommsDay

WHAT IS ACCOUNT MANAGEMENT?Account/project managers support the day-to-day running of their account: they are the glue in a team who make sure projects are completed on brief, on time and...

A day in the life of an Associate Publications Director

Eleanor Raynsford, Associate Publications Director, OPEN Health gives us an insight into a day in the life of her role.

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19

Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time.

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa

Ben Speller shares his thoughts on the value of disease specific congresses

OPEN Health use PR to support clinical trial recruitment

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

OPEN Health | European Congress on Rare Diseases (ECRD) 2020 in 60 seconds

Gavin Jones, Director or Rare Disease, attends the congress to better understand the viewpoints of patient groups, health systems and payers

OPEN Health attend day 2 of the ECRD2020 congress

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

OPEN Health continued support for My Name’5 Doddie

Charity fundraising for Motor Neuron Disease

OPEN Health’s latest partnership with Rare Revolution Magazine

Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)

OPEN Health CSR Report 2019

Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.